Efficacy Evaluation of Sabizabulin Monotherapy Versus Active Control for Treatment of ER+HER2- Metastatic Breast Cancer
Public ClinicalTrials.gov record NCT05079360. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
P2 Efficacy Evaluation of Sabizabulin Monotherapy Versus Active Control for Treatment of ER+HER2- MBC in Patients Who Have Shown Previous Disease Progression on a Nonsteroidal Aromatase Inhibitor, Fulvestrant and CDK 4/6 Inhibitor
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To demonstrate the efficacy of sabizabulin in the treatment of ER+HER2- metastatic breast cancer (MBC) as measured by progression free survival (PFS) by RECIST v1.1.
Study identification
- NCT ID
- NCT05079360
- Recruitment status
- Withdrawn
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- Not listed
Conditions and interventions
Conditions
Interventions
- Sabizabulin Drug
- Exemestane monotherapy, exemestane plus everolimus, or selective estrogen receptor modulator Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 100 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 15, 2023 (Estimated)
- Primary completion
- Mar 30, 2024 (Estimated)
- Completion
- May 26, 2024 (Estimated)
- Last update posted
- Mar 24, 2023
2023 – 2024
United States locations
- U.S. sites
- 26
- U.S. states
- 13
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Alaska Oncology and Hematology, LLC. | Anchorage | Alaska | 99508 | — |
| Ironwood Cancer and Research Centers | Chandler | Arizona | 85224 | — |
| Banner Health/ Banner MD Anderson Cancer Center | Gilbert | Arizona | 85234 | — |
| The Oncology Insitute of Hope and Innovation | Glendale | California | 91204 | — |
| California Research Institute (CRI) | Los Angeles | California | 90027 | — |
| University of California San Francisco Comprehensive Cancer Center | San Francisco | California | 94143 | — |
| Providence Medical Group | Santa Rosa | California | 95043 | — |
| Morton Plant Hospital/ BayCare Health System, Inc | Clearwater | Florida | 33756 | — |
| University of Miami- Sylvester Comprehensive Cancer CenterUniversity of Miami- Sylvester Comprehensive Cancer Center | Miami | Florida | 33146 | — |
| Miami Cancer Institute | Miami | Florida | 33176 | — |
| University Cancer & Blood Center | Athens | Georgia | 30607 | — |
| Blessing Corporate Services | Quincy | Illinois | 62301 | — |
| Touro Infirmary Infusion Center Cancer Care Division-Oncology Research | New Orleans | Louisiana | 70115 | — |
| MBCCOP - LSU Health Sciences Center | Shreveport | Louisiana | 71103 | — |
| Revive Research Institute | Farmington Hills | Michigan | 48073 | — |
| Revive Research Institute | Sterling Heights | Michigan | 48314 | — |
| Astera Cancer Care | East Brunswick | New Jersey | 08816 | — |
| Inspira Medical Center Mullica Hill | Mullica Hill | New Jersey | 08062 | — |
| Inspira Medical Center | Vineland | New Jersey | 08360 | — |
| The Lindner Center for Research and Education at the Christ Hospital | Cincinnati | Ohio | 45219 | — |
| Magee-Women's Hospital | Pittsburgh | Pennsylvania | 15219 | — |
| Tennessee Cancer Specialists | Knoxville | Tennessee | 37909 | — |
| Baptist Clinical Research Institute | Nashville | Tennessee | 38102 | — |
| MultiCare Institute for Research and Innovation | Puyallup | Washington | 98372 | — |
| University of Washington | Seattle | Washington | 98109 | — |
| Cancer Care Northwest | Spokane | Washington | 99216 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05079360, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 24, 2023 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05079360 live on ClinicalTrials.gov.